Fecal Microbiota Transplants Market By Product Type (Frozen FMT, Capsules, Enemas, Lyophilized FMT), By Application Type (Clostridioidesdifficile Infection (CDI), Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Other), By Mode of delivery (Oral, Colonoscopy, Nasogastric Tube, Enema), By End-User (Hospitals, Specialty Clinics, Research Institutions, Home-Based), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Dec 2024 | Report ID: MI1531 | 210 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Product Type

  • Frozen FMT
  • Capsules
  • Enemas
  • Lyophilized FMT

By Application

  • Clostridioides difficile Infection (CDI)
  • Inflammatory Bowel Disease (IBD)
  • Irritable Bowel Syndrome (IBS)
  • Other

By Mode of Delivery

  • Oral
  • Colonoscopic
  • Nasogastric Tube
  • Enema

By End-User

  • Hospitals
  • Specialty Clinics
  • Research Institutions
  • Home-Based

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Rebiotix Inc.
  • Seres Therapeutics
  • OpenBiome
  • Finch Therapeutics
  • Vedanta Biosciences
  • Microbiotica
  • Metabiomics
  • BiomX Inc.
  • Siolta Therapeutics
  • Evelo Biosciences
  • 4D Pharma Plc
  • MaaT Pharma
  • Axial Biotherapeutics
  • Second Genome
  • Quorum Innovations

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing